Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002570596 | SCV003278276 | uncertain significance | not provided | 2024-02-02 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 1141 of the LAMB1 protein (p.Thr1141Met). This variant is present in population databases (rs142551567, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with LAMB1-related conditions. ClinVar contains an entry for this variant (Variation ID: 977874). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002570595 | SCV003692971 | uncertain significance | Inborn genetic diseases | 2024-01-23 | criteria provided, single submitter | clinical testing | The c.3422C>T (p.T1141M) alteration is located in exon 25 (coding exon 24) of the LAMB1 gene. This alteration results from a C to T substitution at nucleotide position 3422, causing the threonine (T) at amino acid position 1141 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Service de Génétique Moléculaire, |
RCV001255792 | SCV001432406 | likely benign | Cobblestone lissencephaly without muscular or ocular involvement | no assertion criteria provided | clinical testing |